2012 America's Neighborhoods-Zip Code 92037 for La Jolla, CA report
- Published: May 2012
- Your are here:
- Home
- Categories
- Company Reports
La Jolla Pharmaceutical Company
La Jolla Pharmaceutical Company
- Published: February 2011
- 1 pages
- Sheila Greco Associates
La Jolla Pharmaceutical Company is a biotechnology company developing therapeutics for antibody-mediated autoimmune diseases and inflammation afflicting several million people worldwide. The Company`s leading product candidate is Riquent for the treatment
| Format | Properties | |
|---|---|---|
| Electronic (PDF) | The report will be emailed to you. The report is sent in PDF format. | This is a single user license, allowing one specific user access to the product. |
Note: Product cover images may vary from those shown
RELATED PRODUCTS
-
FROM
-
Strategic Analysis of Royalty Stacking for Pharmaceutical and Biopharmaceutical Products in Europe
- Language: English
- Published: November 2004
FROM -
eLEARNING - Global Strategic Business Report
- Language: English
- 1091 Pages
- Published: October 2012
- Region: World
FROM -
Distance Learning - Global Outlook
- Language: English
- 230 Pages
- Published: January 2012
- Region: World
FROM -
The Future of the Biodefense Industry: Regulation, Funding Opportunities & Company Profiles
- Language: English
- 183 Pages
- Published: September 2009
- Region: World
FROM -
Israel Life Sciences Market Analysis
- Language: English
- 55 Pages
- Published: June 2011
- Region: Israel
FROM -
Pathology at a Glance. At a Glance
- Language: English
- 256 Pages
- Published: August 2009
-
Latest Guide to Chinese Pharmaceutical GMP Regulations
- Language: English
- 135 Pages
- Published: July 2012
- Region: China
FROM -
Marine Applications of Nuclear Power
- Language: English
- 585 Pages
- Published: May 2013
- Region: World
FROM -
Biodefense Industry - Market to Benefit from Federal Funding such as the BIO EDEP Fund to Support Security Plans
- Language: English
- 49 Pages
- Published: September 2012
- Region: World
FROM
